These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38516533)

  • 21. Antimicrobial Resistance and Antibiotic Consumption in a Secondary Care Hospital in Mexico.
    Dávila-López EC; Berumen-Lechuga MG; Molina-Pérez CJ; Jimenez-Juarez RN; Leaños-Miranda A; Robles-Ordoñez N; Peña-Cano MI; Venegas-Esquivel GA
    Antibiotics (Basel); 2024 Feb; 13(2):. PubMed ID: 38391564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gram-negative ESKAPE bacteria bloodstream infections in patients during the COVID-19 pandemic.
    Alcántar-Curiel MD; Huerta-Cedeño M; Jarillo-Quijada MD; Gayosso-Vázquez C; Fernández-Vázquez JL; Hernández-Medel ML; Zavala-Pineda M; Morales-Gil MÁ; Hernández-Guzmán VA; Bolaños-Hernández MI; Giono-Cerezo S; Santos-Preciado JI
    PeerJ; 2023; 11():e15007. PubMed ID: 37013147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genome plasticity as a paradigm of antibiotic resistance spread in ESKAPE pathogens.
    Das S; Bombaywala S; Srivastava S; Kapley A; Dhodapkar R; Dafale NA
    Environ Sci Pollut Res Int; 2022 Jun; 29(27):40507-40519. PubMed ID: 35349073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial Resistance in ESKAPE Pathogens.
    De Oliveira DMP; Forde BM; Kidd TJ; Harris PNA; Schembri MA; Beatson SA; Paterson DL; Walker MJ
    Clin Microbiol Rev; 2020 Jun; 33(3):. PubMed ID: 32404435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bacteremia due to ESKAPE pathogens: An emerging problem in cancer patients.
    El-Mahallawy HA; Hassan SS; El-Wakil M; Moneer MM
    J Egypt Natl Canc Inst; 2016 Sep; 28(3):157-62. PubMed ID: 27268592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial Resistance in
    Lupo A; Haenni M; Madec JY
    Microbiol Spectr; 2018 Jun; 6(3):. PubMed ID: 30101740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel antimicrobial agents for combating antibiotic-resistant bacteria.
    Chang RYK; Nang SC; Chan HK; Li J
    Adv Drug Deliv Rev; 2022 Aug; 187():114378. PubMed ID: 35671882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical relevance of the ESKAPE pathogens.
    Pendleton JN; Gorman SP; Gilmore BF
    Expert Rev Anti Infect Ther; 2013 Mar; 11(3):297-308. PubMed ID: 23458769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterisation of ESKAPE Pathogens with Special Reference to Multidrug Resistance and Biofilm Production in a Nepalese Hospital.
    Pandey R; Mishra SK; Shrestha A
    Infect Drug Resist; 2021; 14():2201-2212. PubMed ID: 34163185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial susceptibility of Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Asia-Pacific countries: SMART 2013-2015.
    Karlowsky JA; Hoban DJ; Hackel MA; Lob SH; Sahm DF
    J Med Microbiol; 2017 Jan; 66(1):61-69. PubMed ID: 28051952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Occurrence and characterization of ESKAPE organisms on the hands of veterinary students before patient contact at a veterinary academic hospital, South Africa.
    Sebola DC; Oguttu JW; Malahlela MN; Kock MM; Qekwana DN
    BMC Vet Res; 2024 Oct; 20(1):475. PubMed ID: 39420336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extent and Resistance Patterns of ESKAPE Pathogens Isolated in Pus Swabs from Hospitalized Patients.
    Masoud SS; Kovacevich A; Gangji R; Nyawale H; Nyange M; Ntukula A
    Can J Infect Dis Med Microbiol; 2022; 2022():3511306. PubMed ID: 36353409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of Antibiotic Resistance Over Time in a Third-Level University Hospital.
    Scaglione V; Reale M; Davoli C; Mazzitelli M; Serapide F; Lionello R; La Gamba V; Fusco P; Bruni A; Procopio D; Garofalo E; Longhini F; Marascio N; Peronace C; Giancotti A; Gallo L; Matera G; Liberto MC; Cesana BM; Costa C; Trecarichi EM; Quirino A; Torti C
    Microb Drug Resist; 2022 Apr; 28(4):425-435. PubMed ID: 34910885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Essential Metabolic Routes as a Way to ESKAPE From Antibiotic Resistance.
    Barra ALC; Dantas LOC; Morão LG; Gutierrez RF; Polikarpov I; Wrenger C; Nascimento AS
    Front Public Health; 2020; 8():26. PubMed ID: 32257985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel silver nanoparticle-antibiotic combinations as promising antibacterial and anti-biofilm candidates against multiple-antibiotic resistant ESKAPE microorganisms.
    Mishra M; Ballal A; Rath D; Rath A
    Colloids Surf B Biointerfaces; 2024 Apr; 236():113826. PubMed ID: 38447448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Update on the main MDR pathogens: prevalence and treatment options.
    Esposito S; De Simone G
    Infez Med; 2017 Dec; 25(4):301-310. PubMed ID: 29286008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Foodborne ESKAPE Biofilms and Antimicrobial Resistance: lessons Learned from Clinical Isolates.
    Patil A; Banerji R; Kanojiya P; Saroj SD
    Pathog Glob Health; 2021 Sep; 115(6):339-356. PubMed ID: 33851566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of bacterial agents isolated from endotracheal aspirate cultures of Covid-19 general intensive care patients and their antibiotic resistance profiles compared to pre-pandemic conditions.
    Bahçe YG; Acer Ö; Özüdoğru O
    Microb Pathog; 2022 Mar; 164():105409. PubMed ID: 35041973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibiotic resistance in hospital-acquired ESKAPE-E infections in low- and lower-middle-income countries: a systematic review and meta-analysis.
    Ayobami O; Brinkwirth S; Eckmanns T; Markwart R
    Emerg Microbes Infect; 2022 Dec; 11(1):443-451. PubMed ID: 35034585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. VacSol-ML(ESKAPE)
    Nasir S; Anwer F; Ishaq Z; Saeed MT; Ali A
    Vaccine; 2024 Sep; 42(22):126204. PubMed ID: 39126830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.